United States

Back to map

Showing 81-90 of 353 grants

Title Institution Researcher Program Duration Total Award Amount
Protective Genetic and Pharmacological Interventions to Prevent Cytokine and Autoimmune-based Destruction of β cells. Icahn School of Medicine at Mount Sinai Romina Bevacqua Cures 01-April-2025 to 31-March-2027 $559,996.54
Cardiotoxic Circulating Extracellular Vesicles: New Drivers of Type 1 Diabetes-induced Cardiomyopathy Icahn School of Medicine at Mount Sinai Susmita Sahoo Improving Lives 01-April-2025 to 30-September-2026 $199,998.24
Defining antigen-presenting cell – CD8 T cell crosstalk in type 1 diabetes using uLIPSTIC Icahn School of Medicine at Mount Sinai Verena van der Heide Cures 01-May-2026 to 30-April-2029 $600,000.00
Exploiting SDF2L1 to protect against beta cell death and dysfunction in T1D Indiana Biosciences Research Institute Michael Kalwat Cures 01-December-2024 to 30-November-2027 $748,169.00
A multiorgan autoimmune T-cell killing in-vitro platform to improve T1D drug screening Indiana Biosciences Research Institute Roberto Mallone Cures 01-June-2026 to 31-May-2027 $196,040.47
Clinical Translation of T-1123, an Ultra-rapid, Concentrated, Temperature stable Novel Insulin Analog Invictus Therapeutics, LLC Robyn Day Improving Lives 15-October-2025 to 31-May-2027 $1,437,112.00
Advancing T1D Detection and Care Through AI IQVIA, Inc. Nadejda Leavitt Cures 01-February-2025 to 31-October-2026 $345,083.00
Adult T1D Detection at Geisinger IQVIA, Inc. Nadejda Leavitt Cures 01-July-2023 to 30-June-2027 $1,033,123.00
Advanced Preclinical Development of iTOL-101, a Combination Investigational Product Composed of A Biotechnology-Derived Chimeric Streptavidin and A Fas Ligand (SA-FasL) Protein Bound to Biotinylated Hydrogel-Based Microparticles (Microgel) and Mixed with Deceased Donor Human Pancreatic Islets for the Treatment of Poorly-Controlled (or “Brittle”) Type 1 Diabetes iTolerance, Inc. Camillo Ricordi Cures 01-June-2022 to 31-March-2027 $850,000.00
Studies of Promising Functional Endpoints in Eyes of Patients with Diabetes (Protocols AR and AS ) Jaeb Center for Health Research Adam Glassman Improving Lives 01-May-2026 to 30-April-2030 $1,035,583.00